Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, chapter_law, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | chapter_law | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Podiatric Medicine | Podiatric Medicine; Requiring certain podiatric physicians, instead of all podiatric physicians, to complete specified continuing education; authorizing podiatric physicians to perform procedures using cellular or tissue-based products not approved by the United States Food and Drug Administration under certain circumstances; specifying requirements for the cellular or tissue-based products that may be used by such podiatric physicians; requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing procedures using cellular or tissue-based products, etc. | us/states/fl | Florida Legislature | 2026 | SB 1092 | Florida SB 1092 (2026) |
|
enacted | 2026-124 |
|
4 | 33 | 5 | 2026-01-05 | 2026-06-12 | openstates | ocd-bill/55db441a-531d-4b66-ba05-a071755c4f0b | https://flsenate.gov/Session/Bill/2026/1092/ByCategory | eb89f8c681e45dc5bca1398a9d5916f55105b4d78f45cc5b09c9ef008bdf551b | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Florida SB 1092 (2026) — Podiatric Medicine
Podiatric Medicine; Requiring certain podiatric physicians, instead of all podiatric physicians, to complete specified continuing education; authorizing podiatric physicians to perform procedures using cellular or tissue-based products not approved by the United States Food and Drug Administration under certain circumstances; specifying requirements for the cellular or tissue-based products that may be used by such podiatric physicians; requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing procedures using cellular or tissue-based products, etc.
Enacted — Laws of Florida, Chapter 2026-124.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- S 1092 Filed (filed) — source
- S 1092 c1 (committee substitute) — source
- S 1092 c2 (committee substitute) — source
- S 1092 er (enrolled) — source
Votes
- Third Reading — 35–0 (pass) · upper
- Passage, Third Reading — 112–0 (pass) · lower
- Favorable with Committee Substitute — 9–0 (pass) · upper
- Favorable — 23–0 (pass) · upper
- Favorable with Committee Substitute — 11–0 (pass) · upper
Sponsors
- Appropriations Committee on Health and Human Services — primary (organization)
- Health Policy — primary (organization)
- Massullo — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-05 Filed
filing - 2026-01-12 Referred to Health Policy; Appropriations Committee on Health and Human Services; Rules
referral-committee - 2026-01-13 Introduced
introduction - 2026-02-06 On Committee agenda-- Health Policy, 02/11/26, 3:00 pm, 412 Knott Building
- 2026-02-11 CS by Health Policy; YEAS 11 NAYS 0
- 2026-02-12 Pending reference review under Rule 4.7(2) - (Committee Substitute)
- 2026-02-12 Now in Appropriations Committee on Health and Human Services
- 2026-02-13 On Committee agenda-- Appropriations Committee on Health and Human Services, 02/18/26, 8:30 am, 412 Knott Building
- 2026-02-18 CS/CS by Appropriations Committee on Health and Human Services; YEAS 9 NAYS 0
- 2026-02-18 CS by Health Policy read 1st time
- 2026-02-19 Pending reference review under Rule 4.7(2) - (Committee Substitute)
- 2026-02-19 Now in Rules
- 2026-02-19 On Committee agenda-- Rules, 02/24/26, 12:00 pm, 412 Knott Building
- 2026-02-19 CS/CS by Appropriations Committee on Health and Human Services read 1st time
- 2026-02-24 Favorable by- Rules; YEAS 23 NAYS 0
committee-passage-favorable - 2026-02-25 Placed on Calendar, on 2nd reading
- 2026-02-25 Placed on Special Order Calendar, 02/26/26
- 2026-02-26 Read 2nd time
reading-2 - 2026-02-26 Read 3rd time
reading-3 - 2026-02-26 CS passed; YEAS 35 NAYS 0
passage - 2026-02-26 Immediately certified
- 2026-02-26 In Messages
- 2026-03-09 Bill referred to House Calendar
- 2026-03-09 Bill added to Special Order Calendar (3/10/2026)
- 2026-03-09 1st Reading (Committee Substitute 2)
reading-1 - 2026-03-10 Read 2nd time
reading-2 - 2026-03-10 Added to Third Reading Calendar
- 2026-03-10 Read 3rd time
reading-3 - 2026-03-10 CS passed; YEAS 112, NAYS 0
passage - 2026-03-17 Ordered enrolled
enrolled - 2026-06-09 Signed by Officers and presented to Governor
executive-receipt - 2026-06-11 Approved by Governor
executive-signature - 2026-06-12 Chapter No. 2026-124
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/55db441a-531d-4b66-ba05-a071755c4f0b. Confidence: reported (aggregated from official Florida legislature records).